Activ Surgical, a Boston, MA-based digital surgery company, closed a $15m venture capital funding round.
The round was led by Artis Ventures, with participation from LRVHealth, and existing investors DNS Capital, GreatPoint Ventures (GPV), Tao Capital Partners and Rising Tide VC.
The company, which has raised a total of $32m to date, will use funds to accelerate U.S. commercialization and European expansion efforts for its ActivEdge™ platform.
Led by Todd Usen, CEO, Activ Surgical is building a hardware-agnostic platform to enable autonomous and collaborative surgery through the integration of computer vision, artificial intelligence and robotics. ActivEdge™ platform enables existing surgical systems, from scopes to robots, to visualize, characterize and track tissue, in real-time beyond today’s human capability.
In conjunction with this fundraise, the Activ Surgical Board of Directors will expand to include Ameena El-Bibany from ARTIS Ventures and Will Cowen from LRVHealth. They will serve alongside current board members Emily Casey, DNS Capital; Ashok Krishnamurthi, Great Point Ventures; Paul Meister, Independent Board Member; Dr. Peter Kim, Activ Surgical; and Todd Usen, Activ Surgical.